Cornerstone Therapeutics, Inc.
| Nasdaq: CRTX
Cornerstone Therapeutics, Inc. is a specialty pharmaceutical company, which is focused on commercializing products for the hospital, niche respiratory and related specialty markets. The company's strategy is to pursue acquisition or licensing transactions to acquire the rights to patent-protected, branded respiratory or related pharmaceutical products or late stage product candidates, to implement life cycle management, newly acquired products and product candidates that are currently in development. The company was founded on October 31, 2008 and is headquartered in Cary, NC.